Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. (LSTA) — Form 8-K/A: Current report (amendment)
About this filing
Lisata Therapeutics, Inc. (LSTA) filed an amended 8-K on Nov 19, 2026 reporting financial statements and exhibits (Item 9.01).
Key facts
- Item 9.01 · Financial statements and exhibits
More LSTA filings
- S-3/A
Filed Nov 19, 2026
- 8-K
Filed Nov 19, 2026
- 10-Q
Filed Nov 13, 2026
- S-3
Filed Nov 12, 2026
- S-8
Filed Nov 12, 2026
- 8-K/A
Filed Nov 12, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.